• <em>FMR1</em> Disorders
• <em>My 28 Days</em> - a global digital women's health initiative for evaluation and management of secondary amenorrhea: case report and literature review
• A homozygous mutation of TWNK identified in premature ovarian insufficiency warns of late-onset perrault syndrome
• A novel homozygote nonsense variant of MSH4 leads to primary ovarian insufficiency and non-obstructive azoospermia
• A novel missense variant in LAMC1 identified in a POI family by whole exome sequencing
• A novel RNPC3 gene variant expands the phenotype in patients with congenital hypopituitarism and neuropathy
• A qualitative study of work and early menopause: 'On-the job' experiences and career trajectories
• A Review of Hormone and Non-Hormonal Therapy Options for the Treatment of Menopause
• A stepped wedge cluster randomized trial of graphical surveillance of kidney function data to reduce late presentation for kidney replacement therapy
• A Subpathway and Target Gene Cluster-Based Approach Uncovers lncRNAs Associated with Human Primordial Follicle Activation
• Activity, substrate preference and structure of the HsMCM8/9 helicase
• alpha-Ketoglutarate Improves Ovarian Reserve Function in Primary Ovarian Insufficiency by Inhibiting NLRP3-Mediated Pyroptosis of Granulosa Cells
• AMH and other markers of ovarian function in patients with Turner syndrome - a single center experience of transition from pediatric to gynecological follow up
• An uncommon presentation of autoimmune polyglandular syndrome type 1 (APS-1)-A case report
• Biallelic FANCA variants detected in sisters with isolated premature ovarian insufficiency
• Breast Cancer is Increased in Women with Primary Ovarian Insufficiency
• Case report: The evolving phenotype of <em>ESCO2</em> spectrum disorder in a 15-year-old Malaysian child
• Challenging gestational trophoblastic disease cases and mimics: An exemplar for the management of rare tumours
• Clinical pregnancy in Turner syndrome following re-implantation of cryopreserved ovarian cortex
• Cognitive Decline in Early and Premature Menopause
• Current Status and Challenges in Oncofertility for Pediatric Cancer Patients
• CXCL10-based gene cluster model serves as a potential diagnostic biomarker for premature ovarian failure
• Deleterious variants in RNF111 impair female fertility and induce premature ovarian insufficiency in humans and mice
• Diverse genetic causes of amenorrhea in an ethnically homogeneous cohort and an evolving approach to diagnosis
• Donepezil protects against cyclophosphamide-induced premature ovarian failure in mice: A focus on proinflammatory cytokines and NLRP3/TLR-4/NF-kappaB interplay
• Effect of lifestyle or metformin interventions before IVF/ICSI treatment on infertile women with overweight/obese and insulin resistance: a factorial design randomised controlled pilot trial
• Eif4enif1 haploinsufficiency disrupts oocyte mitochondrial dynamics and leads to subfertility
• Exome Sequencing to Identify Novel Variants Associated with Secondary Amenorrhea and Premature Ovarian Insufficiency (POI) in Saudi Women
• Exosomes derived from mesenchymal stem cells attenuate NLRP3-related pyroptosis in autoimmune premature ovarian insufficiency via the NF-kappaB pathway
• Experiences of Female Childhood Cancer Patients and Survivors Regarding Information and Counselling on Gonadotoxicity Risk and Fertility Preservation at Diagnosis: A Systematic Review
• Exploring the triggers of premature and early menopause in India: a comprehensive analysis based on National Family Health Survey, 2019-2021
• Expression of Relaxin Family Peptide Receptors 1 and 3 in the Ovarian Follicle of Japanese Quail
• Factors affecting age at menopause and their relationship with ovarian reserve: a comprehensive review
• Family size for women with primary ovarian insufficiency and their relatives
• Female Reproductive Endocrine Disorders
• Fertility preservation in women with benign gynaecological conditions
• Fragile X Syndrome
• Fragile X Syndrome
• Fragile X Syndrome and FMR1 premutation: results from a survey on associated conditions and treatment priorities in Italy
• Genetic analysis of novel pathogenic gene <em>HROB</em> in a family with primary ovarian insufficiency
• Genetic analysis of novel pathogenic gene HROB in a family with primary ovarian insufficiency
• Genetics of infertility: a paradigm shift for medically assisted reproduction
• Healthcare Experiences of African American Women with the Fragile X Premutation
• Heterozygous Eif4nif1 Stop Gain Mice Replicate the Primary Ovarian Insufficiency Phenotype in Women
• Heterozygous TP63 pathogenic variants in isolated primary ovarian insufficiency
• Homozygous Variant of FANCM of the Fanconi Anemia Pathway Causes Premature Ovarian Insufficiency: Investigation of the Pathogenic Mechanism
• Human mesenchymal stem cells derived exosomes improve ovarian function in chemotherapy-induced premature ovarian insufficiency mice by inhibiting ferroptosis through Nrf2/GPX4 pathway
• Identification of a missense variant of MND1 in meiotic arrest and non-obstructive azoospermia
• Impact of Systemic Therapy on Fertility in Women with Early-Stage Breast Cancer
• Improving diagnostic precision in primary ovarian insufficiency using comprehensive genetic and autoantibody testing
• Inflammasomes in human reproductive diseases
• Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on <em>FMR1</em> Premutation
• LCZ696 (sacubitril/valsartan) mitigates cyclophosphamide-induced premature ovarian failure in rats; the role of TLR4/NF-κB/NLRP3/Caspase-1 signaling pathway
• Low PDE4A expression promoted the progression of ovarian cancer by inducing Snail nuclear translocation
• Mechanoregulation and function of calponin and transgelin
• Model construction and drug therapy of primary ovarian insufficiency by ultrasound-guided injection
• Mutations in CCNB3 affect its location thus causing a multiplicity of phenotypes in human oocytes maturation by aberrant CDK1 activity and APC/C activity at different stages
• Nijmegen Breakage Syndrome
• Novel homozygous variants in PRORP expand the genotypic spectrum of combined oxidative phosphorylation deficiency 54
• Novel Tu translation elongation factor, mitochondrial (TUFM) homozygous variant in a consanguineous family with premature ovarian insufficiency
• Ovarian Morphology in Non-Hirsute, Normo-Androgenic, Eumenorrheic Premenopausal Women from a Multi-Ethnic Unselected Siberian Population
• Pearls &amp; Oy-sters: <em>AARS2</em> Leukodystrophy-Tremor and Tribulations
• Penetrance of pathogenic genetic variants associated with premature ovarian insufficiency
• PGT-M for Premature Ovarian Failure Related to CGG Repeat Expansion of the <em>FMR1</em> Gene
• PGT-M for Premature Ovarian Failure Related to CGG Repeat Expansion of the FMR1 Gene
• Plasma-derived from human umbilical cord blood restores ovarian function and improves serum reproductive hormones levels in mice with premature ovarian insufficiency (POI) through cytokines and growth factors
• Population Estimates of Ovarian Cancer Risk in a Cohort of Patients with Bladder Cancer
• Primary Amenorrhea and Premature Ovarian Insufficiency
• Rapid screening of infertility-associated gynecological conditions via ambient glow discharge mass spectrometry utilizing urine metabolic fingerprints
• Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation
• Risk factors for polycystic ovary syndrome among women of reproductive age in Egypt: A case control study
• Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study
• Spleen function is reduced in individuals with NR5A1 variants with or without DSD: a cross-sectional study
• Systematic review of the association between talc and female reproductive tract cancers
• Thawing fertility: a view of ovarian tissue cryopreservation processes and review of ovarian transplant research
• The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria
• The landscape of genetic variations in non-syndromic primary ovarian insufficiency in the MENA region: a systematic review
• The relationship between primary ovarian insufficiency and gene variations: a prospective case-control study
• The truth about 17-beta estradiol: menopause beyond "old wives' tales"
• The use of fertility treatments among reproductive-aged women after cancer
• Understanding the novel MCM8 gene mutation: primary ovarian insufficiency and uterine hypoplasia in siblings
• What do families affected by Turner Syndrome think of ovarian tissue freezing in childhood?
• Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
• α-Ketoglutarate Improves Ovarian Reserve Function in Primary Ovarian Insufficiency by Inhibiting NLRP3-Mediated Pyroptosis of Granulosa Cells